Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear
NCT ID: NCT00726245
Last Updated: 2011-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
50 participants
INTERVENTIONAL
2008-01-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar Dislocation
NCT00743873
Treatment of ATFL Tears With PRP
NCT00725907
Use of Platelet Rich Plasma After Arthroscopic Debridement for Triangular Fibrocartilage Complex Tears
NCT03805698
Modified Müller's Muscle-conjunctival Resection Internal Ptosis Repair Using Fibrin Glue
NCT03392272
Platelet Rich Plasma in Corneal Surface Diseases
NCT05320172
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
PRGF
PRGF
3-6mg IM (to area of muscle tear)
2
physiological saline
Placebo
3cc IM of physiological saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PRGF
3-6mg IM (to area of muscle tear)
Placebo
3cc IM of physiological saline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 15-40 years old
Exclusion Criteria
* mental or physical disabilities
15 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meir Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Meir Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meir Medicak Center
Kfar Saba, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.